title: Antimicrobial Resistance in Escherichia coli Recovered from Feedlot Cattle and Associations with Antimicrobial Use.
abstract: The objectives of this study were to estimate the prevalence of antimicrobial resistance (AMR) and to investigate the associations between exposures to antimicrobial drugs (AMDs) and AMR in fecal non-type specific Escherichia coli (NTSEC) recovered from a large population of feedlot cattle. Two-stage random sampling was used to select individually identified cattle for enrollment, which were sampled at arrival and then a second time later in the feeding period. Advanced regression techniques were used to estimate resistance prevalences, and to investigate associations between AMD exposures in enrolled cattle and penmates and AMR identified in NTSEC recovered from the second sample set. Resistance was most commonly detected to tetracycline, streptomycin, and sulfisoxazole, and was rarely identified for critically important AMDs. All cattle were exposed to AMDs in feed, and 45% were treated parenterally. While resistance prevalence generally increased during the feeding period, most AMD exposures were not significantly associated with AMR outcomes. Exposures of enrolled cattle to tetracycline were associated with increased resistance to tetracycline and trimethoprim sulfa, while beta-lactam exposures were associated with decreased likelihood of detecting streptomycin resistance. Pen-level AMD exposure measures were not associated with resistance outcomes. These findings suggest that tetracycline treatment of feedlot cattle can be associated with modest increases in risk for recovery of resistant NTSEC, but the numerous treatments with an advanced macrolide (tulathromycin) were not associated with detectable increases in resistance in NTSEC. All cattle were exposed to in-feed treatments of tetracycline and this could limit the ability to identify the full impact of these exposures, but these exposures varied for enrolled cattle varied, providing an opportunity to evaluate a dose response. While AMD exposures were not associated with detectably increased risks for resistance to critically important AMDs, rare resistance outcomes and infrequent exposure to other important AMDs (e.g., cephalosporins) limited our ability to rigorously investigate questions regarding factors that can influence resistance to these important AMDs.
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
authors.forename: Katharine M
authors.initials: KM
authors.lastname: Benedict
authors.affiliation: Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
authors.forename: Sheryl P
authors.initials: SP
authors.lastname: Gow
authors.affiliation: Lethbridge Research Center, University of Lethbridge, Lethbridge, Alberta, Canada.
authors.forename: Tim A
authors.initials: TA
authors.lastname: McAllister
authors.affiliation: Feedlot Health Management Services, Ltd., Okotoks, Alberta, Canada.
authors.forename: Calvin W
authors.initials: CW
authors.lastname: Booker
authors.affiliation: Feedlot Health Management Services, Ltd., Okotoks, Alberta, Canada.
authors.forename: Sherry J
authors.initials: SJ
authors.lastname: Hannon
authors.affiliation: Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Sylvia L
authors.initials: SL
authors.lastname: Checkley
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
authors.forename: Noelle R
authors.initials: NR
authors.lastname: Noyes
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Morley
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002417:Cattle; D024881:Drug Resistance, Bacterial; D004926:Escherichia coli / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents